Anti-MYSM1 antibody [EPR18657] - BSA and Azide free
- RabMAb
- Recombinant
- KO Validated
- What is this?
Be the first to review this product! Submit a review
|
(1 Publication)
Rabbit Recombinant Monoclonal MYSM1 antibody. Carrier free. Suitable for WB, IP and reacts with Human, Mouse, Rat samples. Cited in 1 publication.
View Alternative Names
KIAA1915, MYSM1, Deubiquitinase MYSM1, 2A-DUB
- IP
Supplier Data
Immunoprecipitation - Anti-MYSM1 antibody [EPR18657] - BSA and Azide free (AB251165)
This data was developed using ab193081, the same antibody clone in a different buffer formulation.
MYSM1 was immunoprecipitated from 1mg of HeLa (Human epithelial cell line from cervix adenocarcinoma) whole cell lysate with ab193081 at 1/100 dilution. Western blot was performed from the immunoprecipitate using ab193081 at 1/1000 dilution. VeriBlot for IP Detection Reagent (HRP) (ab131366), was used for detection at 1/1000 dilution.
Lane 1 : HeLa whole cell lysate 10μg (Input).
Lane 2 : ab193081 IP in HeLa whole cell lysate.
Lane 3 : Rabbit monoclonal IgG (ab172730) instead of ab193081 in HeLa whole cell lysate.
Predicted band size : 66kDa, 95kDa.
Blocking and dilution buffer : 5% NFDM/TBST.
Exposure time : 3 minutes.
Two bands detected represent two isoforms.
All lanes:
Immunoprecipitation - Anti-MYSM1 antibody [EPR18657] (<a href='/en-us/products/primary-antibodies/mysm1-antibody-epr18657-ab193081'>ab193081</a>)
Predicted band size: 95 kDa,66 kDa
true
Exposure time: 3min
- WB
Supplier Data
Western blot - Anti-MYSM1 antibody [EPR18657] - BSA and Azide free (AB251165)
This data was developed using ab193081, the same antibody clone in a different buffer formulation.
Blocking and dilution buffer : 5% NFDM/TBST.
Two bands detected represent two isoforms.
All lanes:
Western blot - Anti-MYSM1 antibody [EPR18657] (<a href='/en-us/products/primary-antibodies/mysm1-antibody-epr18657-ab193081'>ab193081</a>) at 1/1000 dilution
Lane 1:
HeLa (Human epithelial cell line from cervix adenocarcinoma) whole cell lysate at 20 µg
Lane 2:
HEK-293 (Human epithelial cell line from embryonic kidney) whole cell lysate at 20 µg
Lane 3:
Jurkat (Human T cell leukemia cell line from peripheral blood) whole cell lysate at 20 µg
Lane 4:
NCCIT (Human pluripotent embryonic carcinoma cell line) whole cell lysate at 20 µg
Lane 5:
K562 (Human chronic myelogenous leukemia cell line from bone marrow) whole cell lysate at 20 µg
Secondary
All lanes:
Western blot - Goat Anti-Rabbit IgG H&L (HRP) (<a href='/en-us/products/secondary-antibodies/goat-rabbit-igg-h-l-hrp-ab97051'>ab97051</a>) at 1/100000 dilution
Predicted band size: 95 kDa
Observed band size: 66 kDa,95 kDa
true
Exposure time: 1min
- WB
Lab
Western blot - Anti-MYSM1 antibody [EPR18657] - BSA and Azide free (AB251165)
This data was developed using ab193081, the same antibody clone in a different buffer formulation.
False colour image of Western blot : Anti-MYSM1 antibody [EPR18657] staining at 1/1000 dilution, shown in green; Mouse anti-GAPDH antibody [6C5] (ab8245) loading control staining at 1/20000 dilution, shown in red. In Western blot, ab193081 was shown to bind specifically to MYSM1. A band was observed at 110 kDa in wild-type HEK-293T cell lysates with no signal observed at this size in MYSM1 knockout cell line ab267297 (knockout cell lysate ab257548). To generate this image, wild-type and MYSM1 knockout HEK-293T cell lysates were analysed. First, samples were run on an SDS-PAGE gel then transferred onto a nitrocellulose membrane. Membranes were blocked in 3 % milk in TBS-0.1 % Tween® 20 (TBS-T) before incubation with primary antibodies overnight at 4°C. Blots were washed four times in TBS-T, incubated with secondary antibodies for 1 h at room temperature, washed again four times then imaged. Secondary antibodies used were Goat anti-Rabbit IgG H&L (IRDye® 800CW) preabsorbed (ab216773) and Goat anti-Mouse IgG H&L (IRDye® 680RD) preabsorbed (ab216776) at 1/20000 dilution.
All lanes:
Western blot - Anti-MYSM1 antibody [EPR18657] (<a href='/en-us/products/primary-antibodies/mysm1-antibody-epr18657-ab193081'>ab193081</a>) at 1/1000 dilution
Lane 1:
Wild-type HEK-293T cell lysate at 20 µg
Lane 2:
MYSM1 knockout HEK-293T cell lysate at 20 µg
Lane 2:
Western blot - Human MYSM1 knockout HEK-293T cell line (<a href='/en-us/products/cell-lines/human-mysm1-knockout-hek-293t-cell-line-ab267297'>ab267297</a>)
Lane 3:
HeLa cell lysate at 20 µg
Lane 4:
RT-4 cell lysate at 20 µg
Predicted band size: 95 kDa
Observed band size: 110 kDa
false
- WB
Supplier Data
Western blot - Anti-MYSM1 antibody [EPR18657] - BSA and Azide free (AB251165)
This data was developed using ab193081, the same antibody clone in a different buffer formulation.
Blocking and dilution buffer : 5% NFDM/TBST.
All lanes:
Western blot - Anti-MYSM1 antibody [EPR18657] (<a href='/en-us/products/primary-antibodies/mysm1-antibody-epr18657-ab193081'>ab193081</a>) at 1/1000 dilution
Lane 1:
RAW 264.7 (Mouse macrophage cell line transformed with Abelson murine leukemia virus) whole cell lysate at 10 µg
Lane 2:
PC-12 (Rat adrenal gland pheochromocytoma cell line) whole cell lysate at 10 µg
Lane 3:
NIH/3T3 (Mouse embryonic fibroblast cell line) whole cell lysate at 10 µg
Secondary
All lanes:
Western blot - Goat Anti-Rabbit IgG H&L (HRP) (<a href='/en-us/products/secondary-antibodies/goat-rabbit-igg-h-l-hrp-ab97051'>ab97051</a>) at 1/100000 dilution
Predicted band size: 95 kDa
Observed band size: 95 kDa
true
Exposure time: 3min
- WB
Supplier Data
Western blot - Anti-MYSM1 antibody [EPR18657] - BSA and Azide free (AB251165)
This data was developed using ab193081, the same antibody clone in a different buffer formulation.
Blocking and dilution buffer : 5% NFDM/TBST.
All lanes:
Western blot - Anti-MYSM1 antibody [EPR18657] (<a href='/en-us/products/primary-antibodies/mysm1-antibody-epr18657-ab193081'>ab193081</a>) at 1/1000 dilution
All lanes:
mESC (Mouse embryonic stem cell line) whole cell lysate at 20 µg
Secondary
All lanes:
Western blot - Goat Anti-Rabbit IgG H&L (HRP) (<a href='/en-us/products/secondary-antibodies/goat-rabbit-igg-h-l-hrp-ab97051'>ab97051</a>) at 1/100000 dilution
Predicted band size: 95 kDa
Observed band size: 95 kDa
true
Exposure time: 8s
Related conjugates and formulations (1)
-
Anti-MYSM1 antibody [EPR18657]
Reactivity data
Product details
ab251165 is the carrier-free version of ab193081.
Patented technology
Our RabMAb® technology is a patented hybridoma-based technology for making rabbit monoclonal antibodies. For details on our patents, please refer to RabMAb® patents.
What are the advantages of a recombinant monoclonal antibody?
This product is a recombinant monoclonal antibody, which offers several advantages including:
- - High batch-to-batch consistency and reproducibility
- - Improved sensitivity and specificity
- - Long-term security of supply
- - Animal-free batch production
For more information, read more on recombinant antibodies.
Conjugation ready
Our carrier-free antibodies are typically supplied in a PBS-only formulation, purified and free of BSA, sodium azide and glycerol. This conjugation-ready format is designed for use with fluorochromes, metal isotopes, oligonucleotides, and enzymes, which makes them ideal for antibody labelling, functional and cell-based assays, flow-based assays (e.g. mass cytometry) and Multiplex Imaging applications.
Use our conjugation kits for antibody conjugates that are ready-to-use in as little as 20 minutes with 1 minute hands-on-time and 100% antibody recovery: available for fluorescent dyes, HRP, biotin and gold.
Compatibility
This product is compatible with the Maxpar® Antibody Labeling Kit from Fluidigm, without the need for antibody preparation. Maxpar® is a trademark of Fluidigm Canada Inc.
Properties and storage information
Form
Storage buffer
Shipped at conditions
Appropriate short-term storage conditions
Appropriate long-term storage conditions
Storage information
Supplementary information
This supplementary information is collated from multiple sources and compiled automatically.
Biological function summary
MYSM1 plays an important role in regulating gene expression during processes like hematopoiesis and immune development. It forms part of a chromatin remodeling complex that modulates transcriptional activity by altering nucleosome configuration. This function is essential for proper stem cell maintenance and differentiation by ensuring that transcriptionally active and inactive regions are appropriately maintained and accessed.
Pathways
MYSM1 participates in the ubiquitin-proteasome pathway and is involved in DNA damage response. It associates closely with proteins like TP53 where it aids in governing cell cycle progression and apoptosis. MYSM1 also interacts with histone modification machinery exerting effects on transcriptional silencing and activation particularly influencing genes associated with immune cell lineage commitment.
Product protocols
- Visit the General protocols
- Visit the Troubleshooting
Target data
Publications (1)
Recent publications for all applications. Explore the full list and refine your search
International journal of biological sciences 21:4027-4050 PubMed40612676
2025
Applications
Unspecified application
Species
Unspecified reactive species
Product promise
Please note: All products are 'FOR RESEARCH USE ONLY. NOT FOR USE IN DIAGNOSTIC OR THERAPEUTIC PROCEDURES'.
For licensing inquiries, please contact partnerships@abcam.com